Allergan’s subsidiaries Forest to pay $38M for bad marketing practices
Allergan’s indirect subsidiaries Forest Laboratories, LLS and Forest Pharmaceuticals, Inc. are about to pay $38 million for bad sales and…
Pharmaceuticals, Biotechnology and Life Sciences
Allergan’s indirect subsidiaries Forest Laboratories, LLS and Forest Pharmaceuticals, Inc. are about to pay $38 million for bad sales and…
French vaccines developer Valneva has closed the share issuance in connection with MVM Life Science Partners LLP`s investment in the…
A biopharmaceutical company TiGenix focused on allogeneic expanded stem cells, has raised $35.65 million gross proceeds from the sale of 2,300,000 American Depository…
Horizon Discovery Group has provided an update on the commercial operation of its Biomanufacturing business with significant growth in cell…
Johnson&Johnson has decreased its shareholding in Biocartis, the Belgian drugmaker said on Wednesday. In a disclosure of a transparency notification,…
Eli Lilly has announced that people who use Lilly insulin will be able to access discounted prices for their purchases…
GSK has announced on Tuesday that it intends to appoint Deloitte LLP (“Deloitte”) as its auditor with effect from the…
OptiBiotix Health has entered into a joint development agreement with a multinational for the development of food and Over The Counter…
The board of directors of Eli Lilly has announced a 2 percent increase in its quarterly dividend. The dividend for…